ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for discussion Register to chat with like-minded investors on our interactive forums.

EMIS Emis Group Plc

1,920.00
0.00 (0.00%)
23 Apr 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type Share ISIN Share Description
Emis Group Plc LSE:EMIS London Ordinary Share GB00B61D1Y04 ORD 1P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  0.00 0.00% 1,920.00 0.00 01:00:00
Industry Sector Turnover Profit EPS - Basic PE Ratio Market Cap
0 0 N/A 0

EMIS Group PLC Purchase of outstanding stake in Rx Systems (9518F)

01/11/2018 7:00am

UK Regulatory


Emis (LSE:EMIS)
Historical Stock Chart


From Apr 2019 to Apr 2024

Click Here for more Emis Charts.

TIDMEMIS

RNS Number : 9518F

EMIS Group PLC

01 November 2018

01 November 2018

EMIS Group plc

("EMIS Group" or "the Group")

Purchase of outstanding minority stake in Rx Systems Limited ("Rx")

EMIS Group is pleased to announce that it has acquired the outstanding minority stake in its subsidiary Rx, which trades as EMIS Health Community Pharmacy, giving the Group 100% control of the business.

The 21.1% minority stake was acquired from Phoenix Medical Supplies Limited ("Phoenix"), the leading pharmaceutical wholesaler, which has held its stake since before EMIS Group acquired 78.9% of Rx in 2010. Phoenix, which owns more than 500 pharmacies in the UK, is a significant user of Rx's systems and services, and is expected to remain an important customer of the Group going forward.

The consideration for the purchase is GBP8.0 million in cash, which has been funded out of EMIS Group's existing cash reserves. Prior to completion, Rx paid a dividend to its shareholders of GBP19.0 million from its accumulated reserves, of which GBP4.0 million was paid to Phoenix with the balance retained within the Group.

For the year ended 31 December 2017, Rx contributed revenues of GBP21.9 million and a segmental operating profit of GBP5.6 million to the Group. The transaction is expected to be immediately earnings enhancing for EMIS Group.

Commenting on the purchase, EMIS Group CEO Andy Thorburn said:

"Rx has been an important contributor to EMIS Group since 2010 and Phoenix a valued partner, co-investor and customer throughout that period. We are pleased to have come to this agreement and to consolidate full control of Rx which, as the market-leading community pharmacy solution, remains central to the Group's strategy of providing connected healthcare software and services across every major UK healthcare setting."

- ENDS -

Enquiries:

For further information, contact:

EMIS Group plc Tel: 0113 380 3000

Andy Thorburn, CEO

Peter Southby, CFO

www.emisgroupplc.com

@EMISGroup

   Numis Securities Limited (Nominated Adviser & Broker)          Tel: 020 7260 1000 

Oliver Hardy/Simon Willis/James Black

MHP Communications Tel: 020 3128 8572

Reg Hoare/Giles Robinson/Patrick Hanrahan/Florence Mayo

emis@mhpc.com

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

END

ACQGMMFGMMGGRZZ

(END) Dow Jones Newswires

November 01, 2018 03:00 ET (07:00 GMT)

1 Year Emis Chart

1 Year Emis Chart

1 Month Emis Chart

1 Month Emis Chart

Your Recent History

Delayed Upgrade Clock